Skip to main navigation Skip to search Skip to main content

Substrate specificity of NovM: Implications for novobiocin biosynthesis and glycorandomization

  • Christoph Albermann
  • , Aileen Soriano
  • , Jiqing Jiang
  • , Heidi Vollmer
  • , John B. Biggins
  • , William A. Barton
  • , Jacob Lesniak
  • , Dimitar B. Nikolov
  • , Jon S. Thorson

Research output: Contribution to journalArticlepeer-review

80 Citations (SciVal)

Abstract

(Matrix presented) In an effort to expand the scope of natural product in vitro glycorandomization (IVG), the substrate specificity of NovM was investigated. A test of four aglycon analogues and over 40 nucleotide sugars revealed NovM has a surprisingly stringent substrate specificity and provided only three new "unnatural" natural products. On the basis of the determined substrate specificity, an alternative to the sugar nucleotide biosynthetic dogma and a cautionary note for the general applicability of IVG are introduced.

Original languageEnglish
Pages (from-to)933-936
Number of pages4
JournalOrganic Letters
Volume5
Issue number6
DOIs
StatePublished - Mar 20 2003

Funding

FundersFunder number
National Childhood Cancer Registry – National Cancer InstituteR01CA084374
National Childhood Cancer Registry – National Cancer Institute

    ASJC Scopus subject areas

    • Biochemistry
    • Physical and Theoretical Chemistry
    • Organic Chemistry

    Fingerprint

    Dive into the research topics of 'Substrate specificity of NovM: Implications for novobiocin biosynthesis and glycorandomization'. Together they form a unique fingerprint.

    Cite this